Moderna shares soared Tuesday as investors placed bets that the pharmaceutical giant’s development of an H5N1 bird flu ...
Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...
The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the ...
U.S. stock futures edge lower after a tech selloff yesterday, investors prepare for a halt to trading tomorrow for the ...
CDC officials say medical professionals are seeing more patients whose illness cannot be traced back to an infected animal or ...